Gal[236Bn]β(1-4)Glc[236Bn]-β-MP is primarily utilized in glycobiology research for studying carbohydrate-protein interactions. It serves as a synthetic glycoside mimic, enabling scientists to investigate the binding mechanisms of lectins and other carbohydrate-binding proteins. This compound is particularly valuable in the development of glycan-based probes for diagnostic applications, helping to identify specific biomarkers associated with diseases such as cancer. Additionally, it is used in the synthesis of complex oligosaccharides, contributing to the advancement of glycoconjugate vaccines and therapeutic agents targeting glycan-mediated processes. Its role in elucidating glycosylation pathways also aids in understanding cellular communication and immune responses.